exv10w18



 







Exhibit 10.18









	 	 	 
	July 11, 2006
	 	 
	 

	 	Emergent BioSolutions Inc.
	 

	 	300 Professional Drive, Suite 250
	 

	 	Gaithersburg. MD 20879
	 
	 	 
	 

	 	t   301 944 0290
	 

	 	f   301 944 0173
	 

	 	www.emergentbiosolutions.com
	Dr. Steven Chatfield
	 	 
	31, Kenwood Drive
	 	 
	Beckingham, Kent
	 	 
	UNITED KINGDOM
	 	 
	 
	 	 
	RE: Role of Chief Scientific Officer
	 	 





Dear Dr. Chatfield:



As you know, your duties as President, Emergent Product Development-UK (formerly Emergent Europe
Limited) are and remain as set forth in your employment agreement dated December 22, 2005.
However, in addition to your serving as President, Emergent Product Development-UK, you have been
appointed as the Chief Scientific Officer (CSO) of Emergent Biosolutions Inc. As of March 1, 2006,
the CSO role changed such that the CSO does not have direct management responsibility for any
department or group.



In light of the foregoing, you agree in performing your responsibilities as CSO of EBSI that:





	 	1.	 	You will spend one week per month in the US and the Maryland corporate offices
attending to the duties related to performing your responsibilities as CSO of Emergent
BioSolutions Inc. These duties and responsibilities are set forth in Attachment 1.
	 
	 	2.	 	You will be flexible regarding travel to the US in excess of one week a month on an
as-needed basis.
	 
	 	3.	 	You will not renew your lease for your Gaithersburg apartment which expires on August
31, 2006 and will no longer receive the monthly $1,900.00 stipend.
	 
	 	4.	 	While you are in the US or elsewhere in the world performing your duties, you will
submit business expenses (e.g., hotel, car rental, business meals, etc.) in accordance with
the Company’s reimbursement policies as they may exist from time to time.




In addition, it is mutually agreed upon that:





	 	1.	 	You are not required to relocate your residence to the US.
	 
	 	2.	 	You will not be required to repay the first portion of the relocation stipend in the
amount of US$15,000.
	 
	 	3.	 	You will no longer receive a per diem payment of $100.00 for each day that you are in
the US on business in fulfilling your CSO responsibilities.
	 
	 	4.	 	You have received reimbursement from the Company of all amounts related to the US$3,000
payment referenced in the penultimate paragraph on page 2 of the September 16, 2005, Letter
Agreement.




This letter memorializes the full understanding of the parties relating to your performance of your
duties as CSO for Emergent BioSolutions Inc. and supersedes and replaces any and all prior letters,
representations, or understandings, oral or written, express or implied with respect thereto,
including, without limitation, your September 16, 2006, Letter Agreement. This Letter Agreement
shall not modify or amend your Employment Agreement with Emergent Product Development-UK, except it
is agreed that the second paragraph of Section 27 is deleted.



Sincerely,



/s/ Paula M. Lazarich




Paula M. Lazarich

Vice President, Human Resources




PML/klr

Attachment




Accepted and agreed

This 11th day of July 2006




	 	 	 
	/s/ S. N. Chatfield
 


	 	 
	Steven N. Chatfield, Ph.D.
	 	 





 









 





Chief Scientific Officer

Duties and Responsibilities



 





	 	1.	 	Present at scientific conferences and meetings
	 
	 	2.	 	Advise CEO, EMC, and Board of Directors on scientific matters and issues
	 
	 	3.	 	Assist Business Development in identifying opportunities and assessing them as they
arise
	 
	 	4.	 	Support corporate interactions in connection with financing and acquisition activities
	 
	 	5.	 	Assist scientific advisory panel in achieving their agreed upon objectives
	 
	 	6.	 	Assist in patent prosecution matters and other actions to advance intellectual property
estate of the Company